| Bioactivity | Tiracizine hydrochloride (AWD-19-166) is a Class I antiarrhythmic drug with activity that reduces myocardial contractile function. Tiracizine hydrochloride was studied in patients with ischemic heart disease, showing its effects on the myocardium. Tiracizine hydrochloride reduces myocardial contractility and may have potential use in the management of heart disease[1]. |
| CAS | 78816-67-8 |
| Formula | C21H26ClN3O3 |
| Molar Mass | 403.90 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. [Correction of the cardiotoxic effect of the anti-arrhythmia agents with befol, sufan, and their combination] |
Tiracizine hydrochloride
CAS: 78816-67-8 F: C21H26ClN3O3 W: 403.90
Tiracizine hydrochloride (AWD-19-166) is a Class I antiarrhythmic drug with activity that reduces myocardial contractile
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.